1,3-Bis(hexafluoro-alpha-hydroxyisopropyl)benzene>98.0%(GC)25g

(5-Bromo-2-chloropyridin-4-yl)boronic acid, 95.0%, 10g

[(3-methylimidazo[2,1-b][1,3]thiazol-6-yl)methyl]amine dihydrochloride hydrate, 95.0%, 250mg

1-(Benzenesulfonyl)-5-bromo-3-iodo-1H-pyrrolo[2,3-b]pyridine, 97%, 1g

4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)aniline, 99.0%, 1g

2-Chloro-6-(methylsulfonyl)pyridine, 95%, 250mg

Cryogenic vials Round bottom outer thread, 2 ml, Lip seal + silicone seal, 100 Piece(s)

4,5-Dichloro-3-nitropyridin-2-amine, 95.0%, 10g

3-Methyl-4-oxo-4,5,6,7-tetrahydro-benzofuran-2-carboxylic acid methyl ester, 95.0%, 250mg

Methyl 2-(6-chloro-5-methylpyridazin-3-yl)acetate, 95%, 100mg

4-Methoxyquinoline-2-carboxylic acid, 97.0%, 5g

4-Nitrosophenol (wetted with ca. 40% Water) (unit weight on dry weight basis)>98.0%(HPLC)(T)25g

2-Bromo-4-(trifluoromethyl)benzoic Acid>98.0%(GC)(T)1g